Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 17, 2026 | CMS / Medicare | Guidance for the Public, Industry, and CMS Staff: Coverage with Evidence DevelopmentNCD · MCDOC27 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Speech Generating DevicesNCD · MCDOC26 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Proposed MEDCAC CharterNCD · MCDOC25 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Renal Denervation for Uncontrolled HypertensionNCD · CAG-00470N__318__cab011ca83 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Removal of ICD-9-CM Code V76.51, Special Screening for Malignant Neoplasms of Colon, From the List of Codes Never Covered by MedicareNCD · CAG-00312N__175__d9df682daa | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | National Coverage Determinations Proposed for Removal (November 2013)NCD · MCDOC24 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Reconstructive Treatments for Facial Lipodystrophy SyndromeNCD · MCDOC20 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Potential NCD TopicsNCD · MCDOC19 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Clinical Pharmacology Compendium Revision Request - CAG-00392NCD · MCDOC17 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Thomson Micromedex DrugDex® Compendium Revision Request - CAG-00391NCD · MCDOC16 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Thomson Micromedex DrugPoints Compendium Revision Request - CAG-00390NCD · MCDOC15 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | NCCN Compendium Revision Request - CAG-00389NCD · MCDOC14 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | AMA-DE Compendium Revision Request - CAG-00388NCD · MCDOC13 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Monitoring of Erythropoietin Stimulating Agents for Beneficiaries with End Stage Renal DiseaseNCD · MCDOC11 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Factors CMS Considers in Referring Topics to the Medicare Evidence Development & Coverage Advisory CommitteeNCD · MCDOC10 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Medical Literature for Local Medicare Contractors to Determine Medically Accepted Indications for Drugs and Biologicals Used Anticancer TreatmentNCD · MCDOC9 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Factors CMS Considers in Commissioning External Technology AssessmentsNCD · MCDOC7 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | INDEPENDENCE iBOT 4000 Mobility System: An Interactive Balancing Mobility SystemNCD · MCDOC5 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Electrodiagnostic Sensory Nerve Conduction ThresholdNCD · CAG-00106N__25__b724bc305b | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Electrocardiographic ServicesNCD · CAG-00158N__89__27bf6ca1c9 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Radioimmunotherapy for Non-Hodgkin's LymphomaNCD · CAG-00163N__38__0649715f4c | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)NCD · CAG-00187N__97__772771d8e3 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)NCD · CAG-00404N__225__d134bf8288 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Cardiac Contractility Modulation (CCM) for Heart Failure (HF)NCD · NCD383 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Transcatheter Aortic Valve Replacement (TAVR)NCD · CAG-00430R2__321__9e09190990 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Obesity as an IllnessNCD · CAG-00108N__57__37edf233d7 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Human Tumor Assay SystemsNCD · CAG-00044N__36__d34adf18c1 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Cardiac RehabilitationNCD · CAG-00089N__18__d79e879d96 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Acupuncture for Nausea after Chemotherapy and Post-operative PainNCD · CAG-00062N__2__a38e519e54 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Prothrombin Time (Addition of ICD-9-CM 289.81, Primary Hypercoagulable State as a Covered Indication)NCD · CAG-00328N__181__0e930fa97a | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Prostate Specific Antigen (Inclusion of ICD-9-CM Code 600.01 for BPH with Urine Obstruction)NCD · CAG-00232N__107__0388ce0873 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of CancerNCD · CAG-00065R__233__17f6ef4a4b | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (N-13 Ammonia) for Myocardial PerfusionNCD · CAG-00165N__66__8cddf0b45e | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (FDG) for Thyroid CancerNCD · CAG-00095N__70__0045baa8aa | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Deep Brain Stimulation for Parkinson's DiseaseNCD · CAG-00124N__21__4b493b5d58 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Cryosurgical Salvage Therapy for Recurrent Prostate CancerNCD · CAG-00064N__20__59430a3747 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Computed Tomographic AngiographyNCD · CAG-00385N__206__61a372ce7f | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (FDG) for Solid TumorsNCD · CAG-00181R4__263__635a6a341e | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (FDG) for Solid TumorsNCD · CAG-00181R__218__635a6a341e | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (FDG) for Soft Tissue Sarcoma (STS)NCD · CAG-00099N__69__45ae56f460 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Positron Emission Tomography (FDG) for Myocardial ViabilityNCD · CAG-00098N__67__793587c39a | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Pharmacogenomic Testing for Warfarin ResponseNCD · CAG-00400N__224__80883b6afd | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Percutaneous Transluminal Angioplasty (PTA) and Stenting of the Renal ArteriesNCD · CAG-00085R4__202__b7002943e6 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Percutaneous Left Atrial Appendage (LAA) Closure TherapyNCD · CAG-00445N__281__bcffc40298 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal StenosisNCD · CAG-00433R__284__a0930aa901 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal StenosisNCD · CAG-00433N__269__a0930aa901 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Ocular Photodynamic Therapy with Verteporfin for Macular DegenerationNCD · CAG-00066R2__60__5a1a1ac018 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Ocular Photodynamic Therapy with Verteporfin for Macular DegenerationNCD · CAG-00066R__59__5a1a1ac018 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Ocular Photodynamic Therapy with Verteporfin for Macular DegenerationNCD · CAG-00066N__58__5a1a1ac018 | Metadata changed |
|---|
| May 17, 2026 | CMS / Medicare | Ocular Photodynamic Therapy (OPT) with Verteporfin for Macular DegenerationNCD · CAG-00066R4__262__81616bcc9b | Metadata changed |
|---|